We are live on
!
Find out more
Emergent Biosolutions
EBS
EBS
198 hedge funds and large institutions have $1.5B invested in Emergent Biosolutions in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 54 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 12
49% more call options, than puts
Call options by funds: $3.1M | Put options by funds: $2.08M
48% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 54
25% more capital invested
Capital invested by funds: $1.2B → $1.5B (+$301M)
9% more funds holding
Funds holding: 181 → 198 (+17)
3.05% more ownership
Funds ownership: 86.95% → 90% (+3.1%)
Holders
198
Holders Change
+17
Holders Change %
+9.39%
% of All Funds
4.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
80
Reduced
54
Closed
12
Calls
$3.1M
Puts
$2.08M
Net Calls
+$1.02M
Net Calls Change
+$4.45M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$12M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.95M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.57M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.32M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$4.87M |
Top Sellers
| 1 |
TA
Teachers Advisors
New York
|
-$9.99M |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$7.71M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.65M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.37M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$3.11M |
